Trial Profile
A Factorial Randomized Controlled Trial of Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary) ; Colecalciferol
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms CANDLE-KIT
- 31 Jan 2019 Status changed from recruiting to discontinued.
- 15 Oct 2018 Planned number of patients changed from 246 to 272.
- 30 Jan 2017 Planned End Date changed from 31 Dec 2019 to 1 Mar 2020.